Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.65 |
| ▸ | HRH1 | P35367 | 1/20 | 0.65 |
| ▸ | TSHR | P16473 | 1/20 | 0.65 |
| ▸ | LMNA | P02545 | 1/20 | 0.63 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.53 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.53 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | KCNA5 | P22460 | 6/20 | 0.51 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL654947 | 0.86 | KCNA5 (0.59) | LMNAKMT2AKCNA5 | |
| Hydrochloric Acid SCHEMBL207813 | 0.85 | KCNA5 (0.58) | LMNAKMT2AKCNA5 | |
| SCHEMBL6966188 | 0.77 | HSD17B10 (0.48) | MAPTALDH1A1HRH1TSHRLMNA | |
| SCHEMBL28473283 | 0.76 | CYP2D6 (0.55) | MAPTALDH1A1TSHRLMNAMEN1 | |
| SCHEMBL31478747 | 0.75 | MAPT (0.58) | MAPTALDH1A1HRH1TSHRLMNA | |
| SCHEMBL15480444 | 0.75 | ALDH1A1 (0.68) | ALDH1A1LMNAMEN1KMT2APOLB | |
| SCHEMBL15134850 | 0.74 | KCNA5 (0.69) | LMNAKMT2AKCNA5 | |
| SCHEMBL15480447 | 0.74 | ALDH1A1 (0.67) | ALDH1A1LMNAMEN1KMT2APOLB | |
| SCHEMBL15480450 | 0.74 | ALDH1A1 (0.67) | ALDH1A1LMNAMEN1KMT2APOLB | |
| SCHEMBL15480445 | 0.74 | ALDH1A1 (0.67) | ALDH1A1LMNAMEN1KMT2APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111467348-A | Application of N- (thiazole-2-yl) -3- (piperazine-1-yl) propanamide derivative in preparation of medicine | 温州医科大学 | 2020-07-31 | — | — | CN | claimed |
| CN-111450095-A | Application of N- (thiazole-2-yl) -3- (piperazine-1-yl) propionamide compound in medicine preparation | 温州医科大学 | 2020-07-28 | — | — | CN | claimed |
| CN-109394764-B | Application of N- (thiazole-2-yl) -3- (piperazine-1-yl) propionamide compound in medicine preparation | 温州医科大学 | 2021-01-15 | — | — | CN | disclosed |
| CN-109394764-B | Application of N- (thiazole-2-yl) -3- (piperazine-1-yl) propionamide compound in medicine preparation | 温州医科大学 | 2021-01-15 | — | — | CN | disclosed |
| CN-109394764-B | Application of N- (thiazole-2-yl) -3- (piperazine-1-yl) propionamide compound in medicine preparation | 温州医科大学 | 2021-01-15 | — | — | CN | disclosed |
| CN-111467348-A | Application of N- (thiazole-2-yl) -3- (piperazine-1-yl) propanamide derivative in preparation of medicine | 温州医科大学 | 2020-07-31 | — | — | CN | disclosed |
| CN-111467348-A | Application of N- (thiazole-2-yl) -3- (piperazine-1-yl) propanamide derivative in preparation of medicine | 温州医科大学 | 2020-07-31 | — | — | CN | disclosed |
| CN-111467348-A | Application of N- (thiazole-2-yl) -3- (piperazine-1-yl) propanamide derivative in preparation of medicine | 温州医科大学 | 2020-07-31 | — | — | CN | disclosed |
| CN-111450095-A | Application of N- (thiazole-2-yl) -3- (piperazine-1-yl) propionamide compound in medicine preparation | 温州医科大学 | 2020-07-28 | — | — | CN | disclosed |
| CN-111450095-A | Application of N- (thiazole-2-yl) -3- (piperazine-1-yl) propionamide compound in medicine preparation | 温州医科大学 | 2020-07-28 | — | — | CN | disclosed |
| CN-111450095-A | Application of N- (thiazole-2-yl) -3- (piperazine-1-yl) propionamide compound in medicine preparation | 温州医科大学 | 2020-07-28 | — | — | CN | disclosed |